Caris Life Sciences
- Market cap
- 7.66B
- P/E (TTM)i
- 72.85
- P/Bi
- 12.94
- EPSi
- -1.90
- Div yieldi
- 0.00%
- 52W posi
- 66%
Anonymous reader poll. Unscientific, not investment advice.
Caris Life Sciences shares were changing hands at 27.10, down 1.29% on the day. Its market capitalisation is about 7.66B, the #1669 most valuable US-listed company we track. Wall Street's 8-analyst consensus lands on Buy, with a price target averaging 27.43 (+1% from here). Over the past year the stock has ranged from 14.19 to 33.65; it now sits 66% up that band.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 1 week.
- Recent price momentum is +20.5% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 4.7% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 27.46
- Open
- 27.10
- Day range
- 26.07 - 27.56
- Avg price
- 27.00
- Volume
- 4.88M
- Turnover
- 131.81M
- Turnover ratei
- 4.21%
- Volume ratioi
- 1.20
- Amplitudei
- 5.45%
- 52-week rangei
- 14.19 - 33.65
Valuation
- P/Ei
- -14.23
- P/E (TTM)i
- 72.85
- P/Bi
- 12.94
- EPSi
- -1.90
- Book value / shi
- 2.09
- Net profit
- -538.06M
- Net assets
- 591.75M
Share structure
- Market cap
- 7.66B
- Float capi
- 3.14B
- Shares out
- 282.60M
- Float sharesi
- 115.84M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2025-06-18
19.5% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-67.13M net over the window
Short interest
- Shares short
- 13.33M
- % of floati
- 4.72%
- Days to coveri
- 3.01
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Caris Life Sciences (CAI)?
Caris Life Sciences last traded at 27.10. The quote on this page refreshes every few seconds while US markets are open.
What is Caris Life Sciences's market cap?
About 7.66B.
What is the P/E ratio of Caris Life Sciences?
The trailing twelve-month P/E is 72.85. The Valuation tab shows it against the stock's own five-year range.
Does Caris Life Sciences pay a dividend?
Caris Life Sciences does not currently pay a regular dividend.
Is Caris Life Sciences a buy according to analysts?
The consensus of 8 analysts is a Buy rating, with an average 12-month price target of 27.43, which implies 1.2% upside from the current price. This is not investment advice.
What is Caris Life Sciences's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Caris Life Sciences a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-10-08 08:29:27 · For reference only, not investment advice and not tailored to your situation.